Evidence map›Paper›PMID 26204951›Full record

ArticleBMC microbiology2015

Identification of the minimal cytolytic unit for streptolysin S and an expansion of the toxin family.

Evelyn M Molloy, Sherwood R Casjens, Courtney L Cox, Tucker Maxson, Nicole A Ethridge, Gabriele Margos, Volker Fingerle, Douglas A Mitchell

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Viruses · 2025
    Article
  3. Article
  4. Enterolyin S, a Polythiazole-containing Hemolytic Peptide from Enterococcus caccae.Chembiochem : a European journal of chemical biology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Bacteriocins ofToxins · 2020
    Article
  11. The Pathogenesis OfInfection and drug resistance · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Evelyn M MolloyCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. emolloy@illinois.edu.
Sherwood R CasjensDivision of Microbiology and Immunology, Department of Pathology, University of Utah Medical School, Salt Lake City, UT, 84112, USA. sherwood.casjens@path.utah.edu.
Courtney L CoxCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. cox22@illinois.edu.
Tucker MaxsonDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. maxson2@illinois.edu.
Nicole A EthridgeSchool of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. nethri2@gmail.com.
Gabriele MargosBavarian Health and Food Safety Authority, National Reference Centre for Borrelia, Oberschleissheim, Germany. gabriele.margos@lgl.bayern.de.
Volker FingerleBavarian Health and Food Safety Authority, National Reference Centre for Borrelia, Oberschleissheim, Germany. volker.fingerle@lgl.bayern.de.
Douglas A MitchellCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. douglasm@illinois.edu.
University of Illinois Urbana-Champaign · USUniversity of Utah · US

Funding

Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
A common denominator of pathogenesis; a rare opportunity for novel therapeutic deDP2OD008463 · OD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI MITCHELL, DOUGLAS ALAN · 2011 to 2011
$2.4M
Comparative Genomics of Lyme Disease SpirochetesR01AI049003 · NIAID · UNIVERSITY OF UTAH · PI CASJENS, SHERWOOD R. · 2002 to 2004
$1.4M
NIAID NIH HHS R01 AI049003NIAID NIH HHS R01 AI49003NIGMS NIH HHS T32 GM070421NIH HHS DP2 OD008463
6 · The paper itself

Abstract

backgroundStreptolysin S (SLS) is a cytolytic virulence factor produced by the human pathogen Streptococcus pyogenes and other Streptococcus species. Related "SLS-like" toxins have been characterized in select strains of Clostridium and Listeria, with homologous clusters bioinformatically identified in a variety of other species. SLS is a member of the thiazole/oxazole-modified microcin (TOMM) family of natural products. The structure of SLS has yet to be deciphered and many questions remain regarding its structure-activity relationships.

resultsIn this work, we assessed the hemolytic activity of a series of C-terminally truncated SLS peptides expressed in SLS-deficient S. pyogenes. Our data indicate that while the N-terminal poly-heterocyclizable (NPH) region of SLS substantially contributes to its bioactivity, the variable C-terminal region of the toxin is largely dispensable. Through genome mining we identified additional SLS-like clusters in diverse Firmicutes, Spirochaetes and Actinobacteria. Among the Spirochaete clusters, naturally truncated SLS-like precursors were found in the genomes of three Lyme disease-causing Borrelia burgdorferi sensu lato (Bbsl) strains. Although unable to restore hemolysis in SLS-deficient S. pyogenes, a Bbsl SLS-like precursor peptide was converted to a cytolysin using purified SLS biosynthetic enzymes. A PCR-based screen demonstrated that SLS-like clusters are substantially more prevalent in Bbsl than inferred from publicly available genome sequences.

conclusionsThe mutagenesis data described herein indicate that the minimal cytolytic unit of SLS encompasses the NPH region of the core peptide. Interestingly, this region is found in all characterized TOMM cytolysins, as well as the novel putative TOMM cytolysins we discovered. We propose that this conserved region represents the defining feature of the SLS-like TOMM family. We demonstrate the cytolytic potential of a Bbsl SLS-like precursor peptide, which has a core region of similar length to the SLS minimal cytolytic unit, when modified with purified SLS biosynthetic enzymes. As such, we speculate that some Borrelia have the potential to produce a TOMM cytolysin, although the biological significance of this finding remains to be determined. In addition to providing new insight into the structure-activity relationships of SLS, this study greatly expands the cytolysin group of TOMMs.

Indexed as

HemolysisBacterial ProteinsCluster AnalysisDNA Mutational AnalysisHumansPhylogenySequence Homology, Amino AcidStreptococcus pyogenesStreptolysinsBacterial Proteinsstreptolysin SStreptolysins

Identifiers

PMID26204951
PMCPMC4513790
OpenAlexW1942328459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.